Investor FAQs
Avalyn is headquartered at 105 W First St, Boston, MA 02127. The main phone number is (206) 707-0340.
Avalyn was founded and commenced operations under the name Genoa Pharmaceuticals in May 2011. The company changed its name to Avalyn Pharma in July 2017.
Avalyn’s initial public offering (IPO) occurred on April 30, 2026.
Avalyn’s fiscal year ends on December 31st.
Avalyn is traded on the NASDAQ Global Market under the ticker symbol AVLN.
Computershare Trust Company, N.A.
150 Royall Street, Suite 101
Canton, MA 02021
www.computershare.com
Deloitte & Touche LLP,
115 Federal St, Winthrop Center
Floors 12-15
Boston, MA 02110
(617) 437-2000
Goodwin Procter LLP,
100 Northern Avenue
Boston, MA 02210
(617) 570-1000
Avalyn’s press release archives can be viewed here .
Avalyn’s SEC filings can be viewed here .
You can submit queries to Avalyn’s investor relations department by contacting ir@avalynpharma.com.